BABA vs BGSI

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

BGSI's Piotroski F-Score of 4/9 indicates weak financial health, signaling deterioration in operational efficiency and profitability trends. The absence of an Altman Z-Score raises concern about bankruptcy risk, especially given a high debt/equity ratio of 1.59 and a current ratio of 0.69, both below safe thresholds. Despite strong earnings growth (284.6% YoY), the company trades at a stretched forward P/E of 39.13 and a current P/E of 218.41, far exceeding sector averages and intrinsic value estimates. The Graham Number ($25.65) and intrinsic value ($21.83) suggest significant overvaluation, with the current price of $161.62 implying a premium driven by speculative growth expectations. Technical trends are bearish, and insider activity is neutral, further undermining confidence.